Effects of ileocolonic delivered vitamin B 2 , B 3 and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn's disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial.

MLA

Otten, Antonius Timotheus, et al. “Effects of Ileocolonic Delivered Vitamin B 2 , B 3 and C (ColoVit) or the Groningen Anti-Inflammatory Diet on Disease Course and Microbiome of Patients with Crohn’s Disease (VITA-GrAID Study): A Protocol for a Randomised and Partially Blinded Trial.” BMJ Open, vol. 13, no. 3, Mar. 2023, p. e069654. EBSCOhost, https://doi.org/10.1136/bmjopen-2022-069654.

APA

Otten, A. T., Peters, V., Barth, I., Stevens, C. L., Bourgonje, A. R., Frijlink, H. W., Harmsen, H. J. M., Rehman, A., Campmans-Kuijpers, M. J. E., & Dijkstra, G. (2023). Effects of ileocolonic delivered vitamin B 2 , B 3 and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn’s disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial. BMJ Open, 13(3), e069654. https://doi.org/10.1136/bmjopen-2022-069654

Chicago

Otten, Antonius Timotheus, V Peters, I Barth, C L Stevens, A R Bourgonje, H W Frijlink, H J M Harmsen, A Rehman, M J E Campmans-Kuijpers, and G Dijkstra. 2023. “Effects of Ileocolonic Delivered Vitamin B 2 , B 3 and C (ColoVit) or the Groningen Anti-Inflammatory Diet on Disease Course and Microbiome of Patients with Crohn’s Disease (VITA-GrAID Study): A Protocol for a Randomised and Partially Blinded Trial.” BMJ Open 13 (3): e069654. doi:10.1136/bmjopen-2022-069654.